Meeting
2015 ASCO Annual Meeting
GLIOSTRY (GLIOblastoma regiSTRY) of the AINO (Italian Association of Neuro-Oncology): Analysis of factors influencing survival in glioblastoma patients receiving the nitrosourea fotemustine at first relapse following Stupp regimen.
Authors
Roberta Ruda
Department of Neuro-Oncology, University of Turin and City of Health and Science, Turin, Italy
Roberta Ruda , Giuseppe Lombardi , Silvia Scoccianti , Maria Grazia Fabrini , Matteo Santoni , Andrea Pace , Antonio Silvani , Alfredo Marinelli , Ivan Lolli , Mario Balducci , Mauro Arcicasa , Maurizio Salvati , Andrea Sponghini , Simona Vallarelli , Manuela Caroli , Francesca Imbesi , Domenico Bilancia , Marina Faedi , Stefano Cascinu , Riccardo Soffietti
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 33, 2015 (suppl; abstr 2054)
DOI
10.1200/jco.2015.33.15_suppl.2054
Abstract #
2054
Poster Bd #
43
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Phase II trial of bevacizumab and temozolomide for upfront treatment of elderly patients with newly diagnosed glioblastoma.
First Author: Phioanh Leia Nghiemphu
Poster
2021 ASCO Annual Meeting
Scalp-sparing radiation with concurrent temozolomide and tumor treating fields (SPARE) for patients with newly diagnosed glioblastoma.
First Author: Ryan C Miller
Poster
2020 ASCO Virtual Scientific Program
Phase II trial of bevacizumab and temozolomide for treatment of elderly patients with newly diagnosed glioblastoma.
First Author: Donna Molaie
Poster
2020 ASCO Virtual Scientific Program
Association of peripheral blood CD4+ T-cell depletion under temozolomide with inferior survival of patients with IDH wildtype glioblastoma.
First Author: Michael Weller